Capital World Investors Applied Molecular Transport Inc. Transaction History

Capital World Investors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.12 - $3.12 $2.61 Million - $7.26 Million	-2,327,255 Reduced 55.56%	1,861,107 $1.81 Million
Q2 2022 Aug 15, 2022	SELL	$2.76 - $7.65 $98,261 - $272,355	-35,602 Reduced 0.84%	4,188,362 $12.2 Million
Q1 2022 May 16, 2022	SELL	$5.63 - $13.88 $9,706 - $23,929	-1,724 Reduced 0.04%	4,223,964 $31.8 Million
Q3 2021 Nov 15, 2021	BUY	$25.87 - $46.61 $718,409 - $1.29 Million	27,770 Added 0.66%	4,225,688 $109 Million
Q2 2021 Aug 16, 2021	BUY	$39.76 - $64.31 $58.4 Million - $94.4 Million	1,468,433 Added 53.8%	4,197,918 $192 Million
Q1 2021 May 14, 2021	BUY	$30.5 - $74.14 $4.99 Million - $12.1 Million	163,553 Added 6.37%	2,729,485 $120 Million
Q4 2020 Feb 12, 2021	BUY	$29.39 - $35.0 $34.5 Million - $41.1 Million	1,173,035 Added 84.22%	2,565,932 $79 Million
Q3 2020 Nov 13, 2020	BUY	$20.49 - $33.58 $20.3 Million - $33.3 Million	990,522 Added 246.17%	1,392,897 $44.3 Million
Q2 2020 Aug 14, 2020	BUY	$17.98 - $28.0 $7.23 Million - $11.3 Million	402,375 New	402,375 $10.1 Million

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.